Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD to Present at the 42nd Annual J.P. Morgan Healthcare Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 42nd Annual...

Key Takeaway: BD (Becton, Dickinson and Company) announced its participation at the 42nd Annual J.P. Morgan Healthcare Conference scheduled for January 9, 2024. The live presentation will be accessible through BD's investor relations website, along with a replay afterwards. As a leading global medical technology company, BD focuses on enhancing health care solutions, improving clinical processes, and advancing diagnostics.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is recognized as one of the largest global medical technology companies.
  • The company is committed to advancing health care through innovative technology.
  • BD actively supports the health care sector by improving medical discovery and diagnostics.

Full Press Release Details

FRANKLIN LAKES, N.J. , Dec. 22, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 10:30 am Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD present at the J.P. Morgan Healthcare Conference?

BD will present on January 9, 2024, at 10:30 am Eastern Time.

Where can I access BD's presentation live webcast?

The live webcast is available at BD's investor relations website.

What is BD's mission in healthcare?

BD aims to improve medical discovery, diagnostics, and care delivery.

How many employees does BD have worldwide?

BD employs over 70,000 people around the globe.

What kind of solutions does BD provide?

BD develops innovative technologies and services for healthcare providers.

Last updated: Dec 22, 2023